BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31472473)

  • 1. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus.
    Leal ES; Adler NS; Fernández GA; Gebhard LG; Battini L; Aucar MG; Videla M; Monge ME; Hernández de Los Ríos A; Acosta Dávila JA; Morell ML; Cordo SM; García CC; Gamarnik AV; Cavasotto CN; Bollini M
    Eur J Med Chem; 2019 Nov; 182():111628. PubMed ID: 31472473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel dengue virus entry inhibitors via a structure-based approach.
    Leal ES; Aucar MG; Gebhard LG; Iglesias NG; Pascual MJ; Casal JJ; Gamarnik AV; Cavasotto CN; Bollini M
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3851-3855. PubMed ID: 28668194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein.
    Zhou Z; Khaliq M; Suk JE; Patkar C; Li L; Kuhn RJ; Post CB
    ACS Chem Biol; 2008 Dec; 3(12):765-75. PubMed ID: 19053243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach.
    Aarthy M; Singh SK
    Curr Top Med Chem; 2018; 18(18):1585-1602. PubMed ID: 30360716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small molecule fusion inhibitor of dengue virus.
    Poh MK; Yip A; Zhang S; Priestle JP; Ma NL; Smit JM; Wilschut J; Shi PY; Wenk MR; Schul W
    Antiviral Res; 2009 Dec; 84(3):260-6. PubMed ID: 19800368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, optimization and antiviral activity of a class of hybrid dengue virus E protein inhibitors.
    Jadav SS; Kaptein S; Timiri A; De Burghgraeve T; Badavath VN; Ganesan R; Sinha BN; Neyts J; Leyssen P; Jayaprakash V
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1747-1752. PubMed ID: 25791449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein.
    Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL
    ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A small-molecule dengue virus entry inhibitor.
    Wang QY; Patel SJ; Vangrevelinghe E; Xu HY; Rao R; Jaber D; Schul W; Gu F; Heudi O; Ma NL; Poh MK; Phong WY; Keller TH; Jacoby E; Vasudevan SG
    Antimicrob Agents Chemother; 2009 May; 53(5):1823-31. PubMed ID: 19223625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitopes based drug design for dengue virus envelope protein: A computational approach.
    Wadood A; Mehmood A; Khan H; Ilyas M; Ahmad A; Alarjah M; Abu-Izneid T
    Comput Biol Chem; 2017 Dec; 71():152-160. PubMed ID: 29096381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide inhibitors against dengue virus infection.
    Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
    Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based screening and validation of potential dengue virus inhibitors through classical and QM/MM affinity estimation.
    Ahmed M; Kumar A; Hobman TC; Barakat K
    J Mol Graph Model; 2019 Jul; 90():128-143. PubMed ID: 31082639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GNF-2 Inhibits Dengue Virus by Targeting Abl Kinases and the Viral E Protein.
    Clark MJ; Miduturu C; Schmidt AG; Zhu X; Pitts JD; Wang J; Potisopon S; Zhang J; Wojciechowski A; Hann Chu JJ; Gray NS; Yang PL
    Cell Chem Biol; 2016 Apr; 23(4):443-52. PubMed ID: 27105280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus.
    Anasir MI; Ramanathan B; Poh CL
    Viruses; 2020 Mar; 12(4):. PubMed ID: 32225021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
    Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
    Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
    de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
    Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel target sites and an inhibitor of the dengue virus E protein.
    Yennamalli R; Subbarao N; Kampmann T; McGeary RP; Young PR; Kobe B
    J Comput Aided Mol Des; 2009 Jun; 23(6):333-41. PubMed ID: 19241120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral drug discovery: Pyrimidine entry inhibitors for Zika and dengue viruses.
    Gallo FN; Marquez AB; Fidalgo DM; Dana A; Dellarole M; García CC; Bollini M
    Eur J Med Chem; 2024 Jun; 272():116465. PubMed ID: 38718623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, and Biological Evaluation of Substituted 4,6-Dihydrospiro[[1,2,3]triazolo[4,5-
    Xu J; Xie X; Ye N; Zou J; Chen H; White MA; Shi PY; Zhou J
    J Med Chem; 2019 Sep; 62(17):7941-7960. PubMed ID: 31403780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the dengue β-OG with serotype-specific alkaloid virtual leads.
    Gangopadhyay A; Chakraborty HJ; Datta A
    J Mol Graph Model; 2017 May; 73():129-142. PubMed ID: 28279821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.